Skip to main content
Premium Trial:

Request an Annual Quote

Nurosene Health, Ontario Institute for Cancer Research Team for Pancreatic Cancer Research

NEW YORK – Artificial intelligence technology developer Nurosene said Wednesday that it has entered into a partnership with the Ontario Institute for Cancer Research (OICR) to identify genetic biomarkers for pancreatic cancer.

Toronto-based Nurosene will be working through its NetraMark subsidiary, which provides AI technology to pharmaceutical and biotechnology researchers working on multiple disease states. Nurosene acquired NetraMark last October.

The firm said that its collaborative research with OICR will help clinicians select the most appropriate therapeutics for individual pancreatic cancer patients. The information will also inform drug discovery and development.

"Applying our technology to identify biomarkers in pancreatic cancer adds to our existing efforts in oncology," Nurosene CSO Joseph Geraci said in a statement. "We are excited to now be working with OICR on this important project that has the potential to have a significant impact on survival rates. This data can be further utilized to discover new therapeutic products in oncology with our current partners."

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.